SPARC has been reported to function as a tumor suppressor in neuroblastoma, breast, pancreatic, lung and ovarian cancers, yet SPARC is associated with highly aggressive tumor phenotypes in melanomas and gliomas [62-64]. This evidence concerns the gene SPARC and neoplasm.